Moderna MRNA 深 沪
等待开盘 08-10 09:30:00 美东时间
59.17
+5.310
+9.86%
华盛通- 最 高59.4496
- 今 开54.62
- 成交量 670.21万股
- 最 低 53.71
- 昨 收 53.86
- 总市值 2354.97万
- 52周最高 85.60
- 市盈率 静 2.09
- 换手率 1683.95%
- 52周最低 22.28
- 委 比 51.00%
- 总股本 0.00亿
- 历史最高 497.49
- 量 比 1.36
- 振 幅 10.66%
- 历史最低 1.10
- 每 手 1
- 风险率 14.38%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Is It Easier To Become A Stock Picker In A Stock Picker's Market?
A few charts I saw recently had me thinking about the challenge of trading individual stocks to generate above-average returns. The first chart came from Citadel’s Scott Rubner. It shows the correlations among
07-14 00:18
Semiconductors And Enterprise Technology Lead Current Order Flow Activity
Source: TradePulse | July 06, 2026 Market Overview Recent aggregate flow data reflects continued institutional participation across several key market segments, with semiconductors, enterprise technology,
07-07 02:45
Stock Of The Day: Will The Moderna Rally Continue?
A classic 'flag' pattern has formed on the chart of Moderna (MRNA). This continuation pattern suggests the rally will continue.
06-29 22:03
FDA Panel Set To Debate Moderna Flu Shot
Moderna flu vaccine faces a key FDA advisory panel review as analysts weigh approval odds, postmarketing study costs, and growth potential.
06-17 20:23
Moderna Strengthens Commercial Strategy As Pipeline Advances
Moderna expands leadership roles and commercial operations as it prepares for multiple vaccine launches and key clinical milestones.
06-17 00:56
Moderna Reports Strong 5-Year Cancer Vaccine Data, Expands CEPI Partnership; Stock Falls
Moderna reports five-year melanoma trial results with Merck and expands its Ebola vaccine partnership with CEPI, but MRNA stock is down.
06-02 00:39
Moderna Flu Shot Heads To FDA Advisory Panel
FDA to review Moderna's experimental mRNA flu shot on June 18 as the agency signals a more transparent approval process.
05-22 02:26
SanDisk's 4,000% Moonshot Just Made Its Parent The Underdog
SanDisk's post-spin rally has turned a separation story into a market-cap upset, with SNDK stock outperforming former parent WDC.
05-12 03:46
Ceva Stock Turns Lower Despite Q1 Double Beat
CEVA, Inc. (NASDAQ:CEVA) shares were trading higher Monday, but have since reversed and began trading lower after the company reported first-quarter financial results.
05-11 22:57
Babcock & Wilcox Stock Gains Following Strong Q1 Results
Babcock & Wilcox Enterprises shares are trading higher Monday after it reported better-than-expected first-quarter financial results.
05-11 21:33
